Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MDGL |
---|---|---|
09:32 ET | 1307 | 256.85 |
09:39 ET | 150 | 255.48 |
09:45 ET | 100 | 255.785 |
09:48 ET | 200 | 254.95 |
09:52 ET | 100 | 254.12 |
09:56 ET | 750 | 253.95 |
09:57 ET | 112 | 253.66 |
10:14 ET | 100 | 253.5 |
10:17 ET | 755 | 253.5 |
10:19 ET | 100 | 252.81 |
10:21 ET | 600 | 253.4 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Madrigal Pharmaceuticals Inc | 5.6B | -9.9x | --- |
Nuvalent Inc | 5.4B | -30.0x | --- |
Avidity Biosciences Inc | 5.2B | -14.9x | --- |
Krystal Biotech Inc | 5.8B | 54.4x | --- |
Immunovant Inc | 4.8B | -16.6x | --- |
BridgeBio Pharma Inc | 4.8B | -9.6x | --- |
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.6B |
---|---|
Revenue (TTM) | $14.6M |
Shares Outstanding | 21.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.43 |
EPS | $-25.50 |
Book Value | $20.39 |
P/E Ratio | -9.9x |
Price/Sales (TTM) | 380.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,622.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.